Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis

bluebird bio and Celgene Corporation Present Initial Data from Ongoing Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy bb21217 in Patients with Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting

Editas Medicine Announces Pre-Clinical Data Supporting Novel Approach for Treatment of Sickle Cell Disease and Beta-Thalassemia

Magenta Therapeutics Presents New Preclinical Data on MGTA-145 Stem Cell Mobilization Product Candidate

bluebird bio Presents Updated Data from Clinical Studies of LentiGlobin Gene Therapy in Transfusion-Dependent β-Thalassemia and Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

bluebird bio to Host Live Webcast of Investor and Analyst Event at the 60th Annual Meeting of the American Society of Hematology

Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101

Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies

Constellation Pharmaceuticals to Present at BMO Healthcare Conference

Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer

Celgene Corporation and bluebird bio Complete Enrollment of Pivotal KarMMa Study of anti-BCMA Car T Cell Therapy bb2121 in Patients with Relapsed and Refractory Multiple Myeloma

Zafgen Provides Update on Investigational New Drug Application for ZGN-1061

Magenta Therapeutics to Host Webcast of Investor and Analyst Event During ASH

Zafgen to Present at the 30th Annual Piper Jaffray Healthcare Conference

Sage Therapeutics to Present at Piper Jaffray 30th Annual Healthcare Conference

Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

Sage Therapeutics Receives Notification of PDUFA Extension for ZULRESSO (brexanolone) Injection

Magenta Therapeutics Appoints Jason Ryan as Chief Operating and Financial Officer

Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference

Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma

Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe

Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018

bluebird bio to Present at the Evercore ISI HealthCONx Conference

Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy

Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference

Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering

REVOLUTION Medicines Announces Presentations at Scientific Meetings in Third and Fourth Quarters of 2018

Jounce Therapeutics Reports Third Quarter 2018 Financial Results

MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions

Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights

CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Pliant Therapeutics Presents Preclinical Data in NASH and PSC at The Liver Meeting 2018

Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results

TARIS Announces Late-Breaking Poster on the Natural History of Muscle-Invasive Bladder Cancer Patients Not Receiving Potentially Curative Therapy

Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results

Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts

Magenta Therapeutics Reports Recent Operational Progress and Third Quarter 2018 Financial Results

Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results

Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

CytomX to Present at the Jefferies 2018 London Healthcare Conference

Editas Medicine Announces Third Quarter 2018 Results and Update

Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference

MyoKardia Reports Third Quarter 2018 Financial Results

MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference

Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors

Nurix Therapeutics to Present at the Stifel Healthcare Conference

Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference

Sage Therapeutics to Present at Stifel 2018 Healthcare Conference

Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights